Hancock Whitney’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.3M Sell
386,551
-1,775
-0.5% -$170K 0.58% 40
2025
Q4
$37.3M Sell
388,326
-11,428
-3% -$1.11M 0.67% 29
2025
Q3
$38.1M Sell
399,754
-2,786
-0.7% -$256K 0.69% 27
2025
Q2
$35.1M Buy
402,540
+373,443
+1,283% +$31.7M 0.67% 31
2025
Q1
$2.61M Buy
29,097
+478
+2% +$42.8K 0.09% 164
2024
Q4
$2.29M Sell
28,619
-4,788
-14% -$414K 0.07% 184
2024
Q3
$3.01M Sell
33,407
-1,871
-5% -$157K 0.1% 147
2024
Q2
$2.78M Sell
35,278
-4,809
-12% -$394K 0.09% 152
2024
Q1
$3.49M Sell
40,087
-9,699
-19% -$828K 0.12% 129
2023
Q4
$4.1M Sell
49,786
-134,997
-73% -$10.3M 0.15% 118
2023
Q3
$14.5M Sell
184,783
-3,561
-2% -$298K 0.6% 40
2023
Q2
$16.6M Sell
188,344
-13,684
-7% -$1.18M 0.65% 35
2023
Q1
$16.3M Buy
202,028
+22,518
+13% +$1.84M 0.65% 33
2022
Q4
$14M Sell
179,510
-43,550
-20% -$3.53M 0.54% 46
2022
Q3
$18M Sell
223,060
-8,925
-4% -$802K 0.77% 28
2022
Q2
$20.8M Sell
231,985
-4,559
-2% -$462K 0.83% 28
2022
Q1
$26.2M Buy
236,544
+2,356
+1% +$249K 0.89% 23
2021
Q4
$24.2M Sell
234,188
-2,998
-1% -$347K 0.76% 27
2021
Q3
$29.7M Buy
237,186
+873
+0.4% +$113K 1.04% 17
2021
Q2
$29.3M Sell
236,313
-2,594
-1% -$326K 0.94% 17
2021
Q1
$28.2M Sell
238,907
-4,719
-2% -$553K 0.96% 16
2020
Q4
$28.5M Sell
243,626
-7,051
-3% -$776K 0.95% 20
2020
Q3
$26.1M Sell
250,677
-13,049
-5% -$1.31M 0.96% 19
2020
Q2
$24.2M Sell
263,726
-22,022
-8% -$2.11M 0.93% 20
2020
Q1
$25.8M Buy
285,748
+60,011
+27% +$6.38M 1.01% 16
2019
Q4
$25.6M Sell
225,737
-6,049
-3% -$664K 0.83% 19
2019
Q3
$25.2M Sell
231,786
-5,887
-2% -$614K 0.83% 15
2019
Q2
$23.1M Sell
237,673
-11,082
-4% -$1.01M 0.74% 15
2019
Q1
$22.7M Buy
248,755
+6,097
+3% +$546K 0.73% 17
2018
Q4
$22.1M Buy
242,658
+113,305
+88% +$10.6M 0.75% 19
2018
Q3
$12.7M Buy
+129,353
New +$12M 0.36% 80
2017
Q1
Sell
-32,576
Closed -$2.32M 583
2016
Q4
$2.32M Buy
32,576
+192
+0.6% +$15.1K 0.09% 252
2016
Q3
$2.8M Sell
32,384
-4,870
-13% -$424K 0.11% 229
2016
Q2
$3.23M Buy
37,254
+111
+0.3% +$8.98K 0.13% 177
2016
Q1
$2.79K Sell
37,143
-2,135
-5% -$161K 0.12% 210
2015
Q4
$3.02M Sell
39,278
-162,670
-81% -$12.2M 0.13% 200
2015
Q3
$13.5M Sell
201,948
-16,736
-8% -$1.23M 0.56% 54
2015
Q2
$17.1M Hold
218,684
0.65% 33
2015
Q1
$17.1M Buy
218,684
+8,398
+4% +$637K 0.65% 33
2014
Q4
$15.2M Buy
210,286
+199,471
+1,844% +$13.9M 0.58% 47
2014
Q3
$670K Sell
10,815
-240
-2% -$15.3K 0.03% 323
2014
Q2
$705K Sell
11,055
-302,019
-96% -$18.3M 0.03% 318
2014
Q1
$19.3M Sell
313,074
-488
-0.2% -$28.4K 0.75% 17
2013
Q4
$18M Sell
313,562
-3,453
-1% -$196K 0.74% 29
2013
Q3
$16.9M Buy
317,015
+5,713
+2% +$307K 0.78% 23
2013
Q2
$16M Buy
+311,302
New +$15.4M 0.8% 24

Other funds holding MDT

Hancock Whitney's MDT Position: Q1 2026 in Review

Hancock Whitney reduced its Medtronic (MDT) stake by 0.46% in Q1 2026, selling an estimated $170K and leaving 386,551 shares worth $33.3M. The position accounts for 0.58% of the portfolio, ranked #40.

Hancock Whitney first reported a position in MDT in Q2 2013 and has held it in 46 quarters since. The position peaked at $38.1M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Hancock Whitney held 386,551 shares of Medtronic worth $33.3M as of Q1 2026.
  • Hancock Whitney sold 1,775 Medtronic shares in Q1 2026, an estimated $170K.
  • Medtronic made up 0.58% of Hancock Whitney's portfolio in Q1 2026, its #40 holding.
  • Hancock Whitney first reported a position in Medtronic in Q2 2013 and has held it in 46 quarters since.
  • Hancock Whitney's Medtronic position peaked at $38.1M in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Hancock Whitney's 13F filing for Q1 2026, filed 15 May 2026.